Bioresorbable polymers synthesized from monomer analogs of natural metabolites
    3.
    发明授权
    Bioresorbable polymers synthesized from monomer analogs of natural metabolites 有权
    由天然代谢物的单体类似物合成的生物可吸收聚合物

    公开(公告)号:US08461289B2

    公开(公告)日:2013-06-11

    申请号:US13482667

    申请日:2012-05-29

    IPC分类号: C08G64/00 C08G63/02

    摘要: New bioresorbable polymers are synthesized from monomer analogs of natural metabolites In particular, polymers are polymerized from analogs of amino acids that contribute advantageous synthesis, processing and material properties to the polymers prepared therefrom, including particularly advantageous degradation profiles.

    摘要翻译: 新的生物可吸收聚合物由天然代谢物的单体类似物合成。特别地,聚合物由氨基酸的类似物聚合,其对由其制备的聚合物有利的合成,加工和材料性质,包括特别有利的降解曲线。

    BIORESORBABLE POLYMERS SYNTHESIZED FROM MONOMER ANALOGS OF NATURAL METABOLITES
    6.
    发明申请
    BIORESORBABLE POLYMERS SYNTHESIZED FROM MONOMER ANALOGS OF NATURAL METABOLITES 有权
    从天然代谢物的单体模拟合成的生物可降解聚合物

    公开(公告)号:US20120197001A1

    公开(公告)日:2012-08-02

    申请号:US13387798

    申请日:2010-07-31

    IPC分类号: C08G69/40

    摘要: This invention discloses biocompatible polymers prepared from monomers (IV), and (IVa), or derivatives thereof, for which the variables are described in the claims and specification. These polymers may be bioresorbable and thus useful for manufacture of medical devices. Therefore, methods for preparing these polymers and medical devices prepared therefrom are also encompassed by this disclosure.

    摘要翻译: 本发明公开了由权利要求和说明书中描述的变体描述的由单体(IV)和(IVa)或其衍生物制备的生物相容性聚合物。 这些聚合物可以是生物可再吸收的,因此可用于制造医疗器械。 因此,制备这些聚合物的方法和由其制备的医疗装置也包括在本公开中。

    BIOCOMPATIBLE POLYMERS FOR MEDICAL DEVICES
    7.
    发明申请
    BIOCOMPATIBLE POLYMERS FOR MEDICAL DEVICES 有权
    用于医疗器械的生物成分聚合物

    公开(公告)号:US20120178885A1

    公开(公告)日:2012-07-12

    申请号:US13387799

    申请日:2010-07-31

    IPC分类号: C08G69/48 C08G69/44

    摘要: The present invention relates to new classes of biocompatible polymers comprising at least one repeating unit derived from a compound of Formula (I) as defined in the claims and specification. These polymers may be biodegradable and bioresorble, and, while not limited thereto, may be adapted for radio-opacity and are useful for medical device applications and controlled release therapeutic formulations. Therefore, methods for preparing these polymers and medical devices prepared therefrom are also encompassed by this disclosure.

    摘要翻译: 本发明涉及包含至少一种衍生自权利要求书和说明书中定义的式(I)化合物的重复单元的新型生物相容性聚合物。 这些聚合物可以是可生物降解的和生物可再生的,并且虽然不限于此,但可适用于无线电透明性,并且可用于医疗器械应用和控制释放治疗制剂。 因此,制备这些聚合物的方法和由其制备的医疗装置也包括在本公开中。

    Hydrazide compounds with angiogenic activity
    10.
    发明授权
    Hydrazide compounds with angiogenic activity 有权
    具有血管生成活性的酰肼化合物

    公开(公告)号:US07838122B2

    公开(公告)日:2010-11-23

    申请号:US12116087

    申请日:2008-05-06

    IPC分类号: C08G65/333 C08F8/30

    摘要: Compounds exhibiting angiogenic properties incorporating the structure of Formula I: R3—NH—NH—C(═O)—R2—P—R1  (I) wherein P is a water-soluble, biodegradable polymer, R1 is hydrogen, lower alkyl, lower alkoxy or —R2—C(═O)—NH—NH—R3; each R2 is independently —CH2—, —NH— or O; and each R3 is independently hydrogen or a residue of a naturally occurring alpha-L-amino acid or dipeptide thereof. Polymer networks crosslinked with hydrazide compounds are also disclosed, together with implantable medical devices incorporating the compounds and crosslinked polymers, and angiogenesis-promoting treatment methods, including wound-treatment methods.

    摘要翻译: 表现出结合式I结构的血管生成特性的化合物:R3-NH-NH-C(= O)-R2-P-R1(Ⅰ)其中P是水溶性可生物降解的聚合物,R1是氢,低级烷基,低级 烷氧基或-R2-C(= O)-NH-NH-R3; 每个R 2独立地是-CH 2 - , - NH-或O; 并且每个R 3独立地是氢或天然存在的α-L-氨基酸或其二肽的残基。 还公开了与酰肼化合物交联的聚合物网络,以及结合有化合物和交联聚合物的可植入医疗装置,以及包括伤口治疗方法在内的血管生成促进治疗方法。